e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Mechanisms of injury and repair in fibrotic, idiopathic or infectious lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is 7.5 mg/Kg of bleomycin safe in inducing pulmonary fibrosis in wistar rats?
S. Maalej, S. BenKhamsa, L. Gharbi, N. Kourda, M. Ben Brahim, F. Tritar (Ariana, Tunis, Tunisia)
Source:
Annual Congress 2007 - Mechanisms of injury and repair in fibrotic, idiopathic or infectious lung disease
Session:
Mechanisms of injury and repair in fibrotic, idiopathic or infectious lung disease
Session type:
Thematic Poster Session
Number:
3484
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Maalej, S. BenKhamsa, L. Gharbi, N. Kourda, M. Ben Brahim, F. Tritar (Ariana, Tunis, Tunisia). Is 7.5 mg/Kg of bleomycin safe in inducing pulmonary fibrosis in wistar rats?. Eur Respir J 2007; 30: Suppl. 51, 3484
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Respiratory physiology
Related content which might interest you:
Effect of simvastatin on bleomycin induced pulmonary fibrosis in rats
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
The effect of montelukast on the monocrotaline induced pulmonary disease in the wistar rat
Source: Eur Respir J 2004; 24: Suppl. 48, 561s
Year: 2004
Can curcuma inhibit bleomycin induced lung fibrosis in rats?
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Effect of oral administration of echinochrome on lipopolysaccharide-induced lung injury in the immature Wistar rats
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
Effect of experimental pulmonary fibrosis induced by bleomycin on the lung fatty acid composition in Wistar rats
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Erythropoietin (EPO) inhibits the bleomycin (BLM)-induced pulmonary fibrosis in rats
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats
Source: Eur Respir J 2001; 17: 1228-1235
Year: 2001
Effect of administration of purified fish oil on bleomycin induced lung fibrosis in rats
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009
Evolution of mediators in the CdCl
2
induced fibrosis in rats
Source: Eur Respir J 2004; 24: Suppl. 48, 103s
Year: 2004
The effect of smoking to oxidative stress on lung tissue of rats with inhaled and intratracheal bleomycin induced pulmonary fibrosis
Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Year: 2007
Pathological evaluation of the bleomycin induced lung injury in rats
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
The effect of dexamethasone on the pulmonary fibrosis of acute lung injury induced by lipopolysaccharide in rats
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007
Effect of intermittent 0.25 ppm ozone exposure in rats with bleomycin-induced pulmonary damage
Source: Eur Respir J 2002; 20: Suppl. 38, 519s
Year: 2002
Effects of drotrecogin-alpha on the bleomycin-induced pulmonary fibrosis in rats
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats
Source: Eur Respir J 2006; 28: Suppl. 50, 827s
Year: 2006
Bevacizumab administration in monocrotaline induced pulmonary arterial hypertension rat model
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
Olodaterol attenuates bleomycin induced lung fibrosis in mice
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Effects of prednisolone and imatinib mesylate on inflammation and fibrosis in amiodarone-induced pulmonary toxicity in rats
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Therapeutic hypercapnia prevents pulmonary hypertension in rats with bleomycin-induced chronic neonatal lung injury
Source: Annual Congress 2011 - Resuscitation and ventilation in the baby and infant
Year: 2011
Effect of fasudil on the bleomycin-induced pulmonary fibrosis and hypertension in mice
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept